Avène Sunsimed KA – Advanced Daily Protection for Skin Prone to Actinic Keratosis
Avène Sunsimed KA is an advanced daily photoprotective medical device developed for skin prone to actinic keratosis (AK) and at increased risk of non-melanoma skin cancer. Formulated with a patented photoprotective complex, it provides very high UVA, UVB and Blue Light protection, helping to reduce the harmful effects of chronic sun exposure. Its lightweight, non-greasy texture makes it ideal for everyday use, offering comfortable, long-lasting protection for vulnerable skin while supporting daily skin cancer prevention as part of a comprehensive sun protection routine.
Advanced Daily Protection for Vulnerable Skin
Targeted Photoprotection
Developed specifically for skin prone to actinic keratosis (AK).
Helps Reduce Skin Cancer Risk
Helps reduce the risk of actinic keratosis (AK) and non-melanoma skin cancer associated with daily sun exposure.*
Very High Broad-Spectrum Protection
Provides advanced protection against UVA, UVB and Blue Light.
Patented Photoprotective Complex
Innovative technology designed for long-lasting daily defence.
Daily Medical-Grade Protection
Lightweight, non-greasy texture suitable for everyday application.
Suitable for Vulnerable Skin
Formulated for photosensitive and high-risk skin requiring daily protection.
Developed for Skin at Increased Risk
Avène Sunsimed KA is specifically developed for individuals with skin prone to actinic keratosis (AK) or those at increased risk of non-melanoma skin cancer due to chronic sun exposure. Unlike conventional sunscreens, it is a medical device formulated to meet the specialised needs of vulnerable skin. Combining Avène's dermatological expertise with advanced photoprotection technology, Sunsimed KA supports long-term skin care by helping protect skin that requires a higher level of defence against the harmful effects of ultraviolet radiation.
Backed by Avène Dermatological Expertise
For over 30 years, Avène has been at the forefront of dermatological skincare, developing innovative solutions for sensitive and vulnerable skin. Sunsimed KA reflects this commitment by combining advanced scientific research with a skin-friendly formulation specifically developed for individuals at increased risk of sun-induced skin damage. As a medical device, it is designed to meet the specialised needs of skin prone to actinic keratosis (AK), delivering advanced photoprotection while maintaining excellent skin tolerance and everyday comfort. Trusted by healthcare professionals worldwide, Avène Sunsimed KA represents the brand's dedication to innovation, efficacy and the long-term care of vulnerable skin.
Supporting Long-Term Skin Health
Protecting vulnerable skin requires more than occasional sun protection—it calls for a consistent, specialised approach. Avène Sunsimed KA is designed to become an integral part of your daily skincare routine, helping to address the cumulative effects of chronic sun exposure. Its lightweight, skin-friendly formula encourages regular use while delivering the advanced photoprotection needed by skin prone to actinic keratosis (AK). By combining dermatological expertise with innovative technology, Sunsimed KA supports long-term skin health and provides confidence in everyday sun exposure.
Awareness Today. Healthier Skin Tomorrow.
Skin cancer is the most common form of cancer worldwide, with the majority of cases linked to excessive exposure to ultraviolet (UV) radiation from the sun. While sun damage may not always be visible, it accumulates over time and can increase the risk of developing both precancerous skin lesions, such as actinic keratosis (AK), and non-melanoma skin cancers.
Actinic keratosis is a common precancerous skin condition caused by long-term sun exposure. If left untreated, some lesions may progress to squamous cell carcinoma, highlighting the importance of early detection and appropriate management. Discover more about specialised photoprotection for skin affected by actinic keratosis and oncology treatments.
Protecting your skin every day is one of the most effective ways to reduce the harmful effects of cumulative UV exposure. Wearing protective clothing, seeking shade during peak sunlight hours, performing regular skin self-examinations, and using appropriate photoprotection are simple steps that can help maintain healthy skin and reduce the risk of sun-related skin damage. Read our guide to sun exposure, skin cancer and everyday skin protection for further practical advice.
If you notice any new, changing or unusual skin lesions, consult your doctor or dermatologist for a professional skin assessment. Early diagnosis and timely treatment play a vital role in achieving the best possible outcomes.
Skin Cancer Facts
Skin cancer is the most common cancer worldwide.
Around 90% of non-melanoma skin cancers are associated with ultraviolet (UV) radiation exposure.
Actinic keratosis (AK) is a common precancerous skin lesion caused by cumulative sun exposure.
Early detection and consistent sun protection can significantly reduce the risk of developing advanced skin disease.
Avène Sunsimed KA – Advanced Daily Protection for Skin Prone to Actinic Keratosis
Avène Sunsimed KA is an advanced daily photoprotective medical device developed for skin prone to actinic keratosis (AK) and at increased risk of non-melanoma skin cancer. Formulated with a patented photoprotective complex, it provides very high UVA, UVB and Blue Light protection, helping to reduce the harmful effects of chronic sun exposure. Its lightweight, non-greasy texture makes it ideal for everyday use, offering comfortable, long-lasting protection for vulnerable skin while supporting daily skin cancer prevention as part of a comprehensive sun protection routine.
Advanced Daily Protection for Vulnerable Skin
Targeted Photoprotection
Developed specifically for skin prone to actinic keratosis (AK).
Helps Reduce Skin Cancer Risk
Helps reduce the risk of actinic keratosis (AK) and non-melanoma skin cancer associated with daily sun exposure.*
Very High Broad-Spectrum Protection
Provides advanced protection against UVA, UVB and Blue Light.
Patented Photoprotective Complex
Innovative technology designed for long-lasting daily defence.
Daily Medical-Grade Protection
Lightweight, non-greasy texture suitable for everyday application.
Suitable for Vulnerable Skin
Formulated for photosensitive and high-risk skin requiring daily protection.
Developed for Skin at Increased Risk
Avène Sunsimed KA is specifically developed for individuals with skin prone to actinic keratosis (AK) or those at increased risk of non-melanoma skin cancer due to chronic sun exposure. Unlike conventional sunscreens, it is a medical device formulated to meet the specialised needs of vulnerable skin. Combining Avène's dermatological expertise with advanced photoprotection technology, Sunsimed KA supports long-term skin care by helping protect skin that requires a higher level of defence against the harmful effects of ultraviolet radiation.
Backed by Avène Dermatological Expertise
For over 30 years, Avène has been at the forefront of dermatological skincare, developing innovative solutions for sensitive and vulnerable skin. Sunsimed KA reflects this commitment by combining advanced scientific research with a skin-friendly formulation specifically developed for individuals at increased risk of sun-induced skin damage. As a medical device, it is designed to meet the specialised needs of skin prone to actinic keratosis (AK), delivering advanced photoprotection while maintaining excellent skin tolerance and everyday comfort. Trusted by healthcare professionals worldwide, Avène Sunsimed KA represents the brand's dedication to innovation, efficacy and the long-term care of vulnerable skin.
Supporting Long-Term Skin Health
Protecting vulnerable skin requires more than occasional sun protection—it calls for a consistent, specialised approach. Avène Sunsimed KA is designed to become an integral part of your daily skincare routine, helping to address the cumulative effects of chronic sun exposure. Its lightweight, skin-friendly formula encourages regular use while delivering the advanced photoprotection needed by skin prone to actinic keratosis (AK). By combining dermatological expertise with innovative technology, Sunsimed KA supports long-term skin health and provides confidence in everyday sun exposure.
Awareness Today. Healthier Skin Tomorrow.
Skin cancer is the most common form of cancer worldwide, with the majority of cases linked to excessive exposure to ultraviolet (UV) radiation from the sun. While sun damage may not always be visible, it accumulates over time and can increase the risk of developing both precancerous skin lesions, such as actinic keratosis (AK), and non-melanoma skin cancers.
Actinic keratosis is a common precancerous skin condition caused by long-term sun exposure. If left untreated, some lesions may progress to squamous cell carcinoma, highlighting the importance of early detection and appropriate management. Discover more about specialised photoprotection for skin affected by actinic keratosis and oncology treatments.
Protecting your skin every day is one of the most effective ways to reduce the harmful effects of cumulative UV exposure. Wearing protective clothing, seeking shade during peak sunlight hours, performing regular skin self-examinations, and using appropriate photoprotection are simple steps that can help maintain healthy skin and reduce the risk of sun-related skin damage. Read our guide to sun exposure, skin cancer and everyday skin protection for further practical advice.
If you notice any new, changing or unusual skin lesions, consult your doctor or dermatologist for a professional skin assessment. Early diagnosis and timely treatment play a vital role in achieving the best possible outcomes.
Skin Cancer Facts
Skin cancer is the most common cancer worldwide.
Around 90% of non-melanoma skin cancers are associated with ultraviolet (UV) radiation exposure.
Actinic keratosis (AK) is a common precancerous skin lesion caused by cumulative sun exposure.
Early detection and consistent sun protection can significantly reduce the risk of developing advanced skin disease.